Assessment of Antibody Stability in a Novel Protein-Free Serum Model
Therapeutic proteins can degrade upon administration as they are subjected to a variety of stresses in human body compartments. In vivo degradation may cause undesirable pharmacokinetic/pharmacodynamic profiles. Pre-clinical in vitro models have gained scientific interest as they enable one to evalu...
Main Authors: | Joachim Schuster, Vinay Kamuju, Roman Mathaes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/6/774 |
Similar Items
-
The effect of temperature on the stability of PCSK-9 monoclonal antibody: an experimental study
by: Tanawan Kongmalai, et al.
Published: (2021-02-01) -
Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01) -
Regulatory Approved Monoclonal Antibodies Contain Framework Mutations Predicted From Human Antibody Repertoires
by: Brian M. Petersen, et al.
Published: (2021-09-01) -
Safety issues of monoclonal antibodies used in rheumatology
by: A. V. Philippova, et al.
Published: (2020-01-01) -
Bispecific antibodies: design, therapy, perspectives
by: Sedykh SE, et al.
Published: (2018-01-01)